Press releases

Month Year

Email alerts

Dec 17, 2012

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

Published data demonstrate the Symplicity(TM) renal denervation system provides blood pressure reduction in patients with treatment-resistant hypertension sustained to 12 months

MINNEAPOLIS - December 17, 2012 - Medtronic, Inc. (NYSE: MDT) today announced that one-year results from Symplicity HTN-2, the first randomized clinical trial investigating renal denervation, were...
Dec 12, 2012

Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference

MINNEAPOLIS - Dec 4, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Oppenheimer 23rd Annual Healthcare Conference on...
Dec 10, 2012

Medtronic CEO Omar Ishrak to Speak at JP Morgan Healthcare Conference

MINNEAPOLIS - Dec 10, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the JP Morgan 31st Annual Healthcare Conference on...
Dec 6, 2012

Medtronic Introduces Cervical Facetlift(SM) ID/S Surgical Technique

MEMPHIS, Tenn. - Dec. 6, 2012 - Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced the U.S. launch of the company's latest addition to their cervical surgical technique...
Dec 6, 2012

Medtronic Announces Accelerated Cash Dividend for Third Quarter of Fiscal Year 2013

MINNEAPOLIS - December 6, 2012 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.26 per share of the Company's common stock. The dividend is payable on...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa